NPPES file of Aug 9, 2026

Daniel C. Su, M.D.

Retina Specialist (Ophthalmology) Physician · Los Angeles, CA

Daniel C. Su, M.D. is a retina specialist (ophthalmology) physician with a practice address in Los Angeles, California, and NPI 1508109133, issued on Apr 2, 2013. Check the license (California A134110, as entered in NPPES) on the Medical Board of California; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2023 and 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1508109133
Name
Daniel C. Su
Credential
M.D.
Primary taxonomy
Retina Specialist (Ophthalmology) Physician 207WX0107X
License numbers
A134110 CA
MD460411 PA
Self-reported in NPPES; status is on the state search
Practice location
1245 Wilshire Blvd Ste 380, Los Angeles, CA 90017
Phone
(213) 483-8810
Enumerated
Apr 2, 2013
Record last updated
Aug 12, 2019 (not updated in 7 years: call before relying on the address or phone)
Fax
(213) 975-9118
Medicare enrollment
Enrolled (PECOS I20190722001869); accepts Medicare assignment
Medical or professional school
Icahn School Of Medicine At Mount Sinai, 2013
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 1245 Wilshire Blvd Ste 380

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. David Boyer, MDOphthalmology Physician1295736916
  2. Thomas Chu, MDOphthalmology Physician1760482806
  3. David Liao, M.D.,PH.D.Ophthalmology Physician1962541847
  4. Douglas MatsunagaOphthalmology Physician1821450818
  5. Jeffrey Tan, M.D.Ophthalmology Physician1033407549

Verify Daniel C. Su in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersMedical Board of California
    Search for license A134110
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the California license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

4% more Medicare Part D claims than the average retina specialist (ophthalmology) physician in 2024

647 Medicare Part D claims for 206 beneficiaries, against an average of 620 among the 1,449 providers of this specialty who prescribed in Part D. Brand-name drugs were 42% of claims.

  1. Daniel Su647
  2. Specialty average620

Most prescribed

  1. Prednisolone Acetate152 claims
  2. Brimonidine Tartrate79 claims
  3. Dorzolamide-Timolol70 claims
  4. Latanoprost64 claims
  5. Moxifloxacin55 claims
  6. Combigan25 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 100 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

  1. Qualityout of 100 · 30% of the final score100.0
  2. Costnot scored (reweighted)
  3. Promoting interoperabilitynot scored (reweighted)
  4. Improvement activities40 of 40 points · 15%100.0

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $11,059.60

27 payments; by number, the most common kind was food and beverage; the largest payer was Abbvie Inc. The 1,253 providers of this specialty with any payment received $7,667.49 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Daniel Su$11,060
  2. Specialty average$7,667

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through one group practice

  1. Retina Vitreous Associates Medical GroupLos Angeles, CA

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

Daniel C. Su among 205 retina specialist (ophthalmology) physician records in California

Daniel C. Su, M.D. is one of 205 retina specialist (ophthalmology) physician records with a practice address in California. 98% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2013, is newer than 65% of them.

  • NPI issued2013 · 65% of these records are older, 32% newer
  • In a Medicare fileYes · 98% of these records are
  • In the CMS Doctors and Clinicians fileYes · 92% of these records are
  • Graduated2013 · median 2007 among the 189 with a school on file
  • Record last updated2019 · 37% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207WX0107X and a California practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

Retina Specialist (Ophthalmology) Physician providers in California

There are 205 retina specialist (ophthalmology) physician records in California.

The 8 retina specialist (ophthalmology) physician records with the nearest ZIP codes

  1. Hans Kim, M.D.Los Angeles, CA 900201710093182
  2. David Lazar, M.D.Los Angeles, CA 900251417242975
  3. Rodrigo Fernandes, MD, PHDLos Angeles, CA 900331144949306
  4. Juan Carlos Martinez Camarillo, MDLos Angeles, CA 900331598379208
  5. Tarek Alasil, MDLos Angeles, CA 900451003072786
  6. Joseph TranLos Angeles, CA 900891215678586
  7. Adrian Au, MDLos Angeles, CA 900951124482450
  8. Aya Barzelay WollmanLos Angeles, CA 900951093592172

Common questions

What is Daniel C. Su, M.D.'s NPI number?

Daniel C. Su, M.D.'s National Provider Identifier (NPI) is 1508109133, issued on Apr 2, 2013. An NPI identifies a provider in billing; it is not a license.

Where is Daniel C. Su, M.D. located?

The NPPES record lists a practice address at 1245 Wilshire Blvd Ste 380, Los Angeles, CA, 90017. Phone: (213) 483-8810. Providers update this record themselves, so call before visiting.

How can I verify Daniel C. Su, M.D.'s license?

NPPES lists California license number A134110, as entered by the provider. Search the Medical Board of California at https://www.mbc.ca.gov/License-Verification/default.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Daniel C. Su, M.D. prescribe under Medicare Part D?

In 2024, Daniel C. Su, M.D. had 647 Medicare Part D claims for 206 beneficiaries; the average among retina specialist (ophthalmology) physician prescribers was 620. Part D covers Medicare prescriptions only.

What is Daniel C. Su, M.D.'s MIPS final score?

The 2023 MIPS final score is 100 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.